The effects of hydrogen treatment in a cigarette smoke solution-induced chronic obstructive pulmonary disease-like changes in an animal model
- PMID: 36524091
- PMCID: PMC9745525
- DOI: 10.21037/jtd-22-324
"V体育官网入口" The effects of hydrogen treatment in a cigarette smoke solution-induced chronic obstructive pulmonary disease-like changes in an animal model
Erratum in
-
Erratum to the effects of hydrogen treatment in a cigarette smoke solution-induced chronic obstructive pulmonary disease-like changes in an animal model.J Thorac Dis. 2023 Feb 28;15(2):942. doi: 10.21037/jtd-2022-22. Epub 2023 Feb 3. J Thorac Dis. 2023. PMID: 36910119 Free PMC article.
Abstract
Background: Molecular hydrogen, with its antioxidant and anti-inflammatory properties, may be suitable for the prevention and treatment of chronic obstructive pulmonary disease (COPD) VSports手机版. This study aims to investigate the therapeutic efficacy of hydrogen-oxygen (H2/O2) treatment in cigarette smoke solution (CSS)-induced COPD-like injury in a female BALB/c mouse model. .
Methods: Thirty mice were randomly assigned to three groups: Control (n=8), COPD (n=10), and COPD + H2/O2 (n=12). CSS was administered by intraperitoneal (IP) injection twice weekly for 6 weeks during the COPD induction phase. Simultaneously, the COPD + H2/O2 group started received 75 minutes of inhalation therapy (42% H2) delivered by the Oxy-Hydrogen Generator twice daily for 9 weeks V体育安卓版. Mice body weights and survival were measured throughout the study period. Neutrophil elastase (NE) activity and lung histopathological changes were also evaluated. .
Results: The results showed a higher survival rate in the COPD + H2/O2 group compared to the COPD group (100% vs V体育ios版. 80%) during the induction phase. Slight decreases in body weight gains were observed in the COPD and COPD + H2/O2 groups during the first 15 days of the induction phase, but there was no significant difference in mean body weights among the three groups throughout the study period. NE activity was numerically lower in the COPD + H2/O2 group compared to the COPD group. The histopathological evaluation showed significant improvements in the H2/O2-treated mice with respect to mean linear intercept (MLI) and lesion (inflammation and emphysema) scores. Improvements in goblet cell hypertrophy and hyperplasia of airway epithelium were not significant. .
Conclusions: A 9-week H2/O2 inhalation therapy delivered by the Oxy-Hydrogen Generator to CSS-induced COPD-like injury in mice showed improvement in survival rate, alveolar structural changes, and histopathological lesion scores of the lung. VSports最新版本.
Keywords: Hydrogen gas; chronic obstructive pulmonary disease (COPD); inflammation; oxidative stress. V体育平台登录.
2022 Journal of Thoracic Disease. All rights reserved VSports注册入口. .
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd. amegroups. com/article/view/10. 21037/jtd-22-324/coif). HJY, WHT, HMS, KYW, and FLD reports funding from HOHO Biotech Co. , Ltd. HJY is the medical advisor of HOHO Biotech. KYW is the founder of HOHO Biotech. WHT is the employee of HOHO Biotech V体育官网入口. HMS and FLD are board members of HOHO Biotech. HMS is the person in charge for IPC Intellectual Property Connections, INC. She declares that IPC Intellectual Property Connections, INC. has no relationship with HOHO and does not have any interest in the publication of the present article. The other authors have no conflicts of interest to disclose.
Figures






References
-
- WHO. The top 10 causes of death. World Health Organization, 2020. Available online: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (V体育官网入口)
-
- Hassett DJ, Borchers MT, Panos RJ. Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives. J Microbiol 2014;52:211-26. 10.1007/s12275-014-4068-2 - DOI (V体育ios版) - PubMed
-
- Halpin DMG, Criner GJ, Papi A, et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2021;203:24-36. 10.1164/rccm.202009-3533SO - DOI - PMC - PubMed